The Conversion Problem Nobody Talks About
Plant-based omega-3 supplements — flaxseed oil, chia seeds, walnuts — contain ALA (alpha-linolenic acid). Fish oil contains EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). These are all omega-3 fatty acids, but they are not interchangeable. The human body can theoretically convert ALA to EPA and DHA, but the conversion rate is so low that it cannot substitute for direct dietary intake of EPA and DHA.
This article examines the peer-reviewed research on ALA conversion efficiency and what it means for omega-3 supplementation decisions. No therapeutic claims are made. These statements have not been evaluated by the Food and Drug Administration.
The Numbers That Matter
- ALA → EPA conversion: Typically 0.2%–8% in humans — most studies find below 5%
- ALA → DHA conversion: Typically below 0.5%
- Fish oil: Delivers EPA and DHA directly — no conversion required
- Implication: 1,000 mg ALA from flaxseed yields approximately 20–50 mg EPA and less than 5 mg DHA
The Three Omega-3 Fatty Acids Explained
| Fatty Acid | Full Name | Primary Sources | Body Makes It? |
|---|---|---|---|
| ALA | Alpha-linolenic acid | Flaxseed, chia, walnuts, hemp | No — must come from diet |
| EPA | Eicosapentaenoic acid | Fatty fish, fish oil, algae oil | Only via inefficient ALA conversion |
| DHA | Docosahexaenoic acid | Fatty fish, fish oil, algae oil | Only via very inefficient ALA conversion |
ALA is an essential fatty acid — the body cannot synthesise it and it must come from food. EPA and DHA are technically non-essential because the body can make them from ALA, but the conversion is so inefficient that they behave as conditionally essential in practice.
Why Conversion Is So Inefficient
ALA conversion to EPA and DHA depends on a series of desaturase and elongase enzymes — specifically delta-6 desaturase (D6D) and delta-5 desaturase (D5D). These enzymes have two critical limitations.
1. Competition with Omega-6 Fatty Acids
The same desaturase enzymes used to convert ALA are also required to metabolise linoleic acid (LA) — the dominant omega-6 fatty acid in most Western diets. Typical Western diets contain an omega-6 to omega-3 ratio of 15:1 or higher. At these ratios, LA outcompetes ALA for enzyme access, significantly reducing ALA conversion efficiency.
2. Enzyme Rate Limitation
Even without omega-6 competition, D6D is the rate-limiting enzyme in the conversion pathway. It has limited capacity, and a significant proportion of ALA is diverted to beta-oxidation (used as energy) rather than converted to EPA. Studies consistently show that even when ALA intake is high, EPA and DHA levels in blood and tissue remain low unless preformed EPA and DHA are consumed directly.
What the Research Shows
A systematic review of ALA conversion studies published in the American Journal of Clinical Nutrition found that in healthy adults, conversion of ALA to EPA ranged from approximately 0.2% to 8%, with DHA conversion consistently below 0.5%. A study specifically examining vegans — who have higher ALA intake and lower omega-6 competition from animal-derived LA — still found substantially lower EPA and DHA blood levels than omnivores consuming fish.
The implication is straightforward: a person consuming 2,000 mg of ALA from flaxseed oil daily is likely achieving less than 100 mg of actual EPA and negligible DHA. The standard recommendation for general health maintenance is 250–500 mg combined EPA+DHA — a threshold that plant-based sources alone typically cannot meet.
Who Is Most Affected
- Vegans and vegetarians — no dietary EPA or DHA unless supplementing with algae oil
- Older adults — desaturase enzyme activity declines with age, reducing already-limited conversion
- People with metabolic syndrome — insulin resistance impairs D6D activity
- Pregnant women — DHA demand for foetal brain development cannot be met by ALA conversion
- People with high omega-6 intake — competitive inhibition reduces ALA conversion further
The Practical Conclusion
ALA from plant sources contributes to omega-3 intake but cannot substitute for preformed EPA and DHA. People who do not consume 2–3 servings of fatty fish per week — whether for dietary, allergy, or preference reasons — require a direct source of EPA and DHA. Fish oil in natural triglyceride form (as in NeoLife Omega 3 Plus) provides EPA and DHA without relying on conversion. Algae-derived EPA and DHA is the alternative for those avoiding fish-derived sources.
Frequently Asked Questions
Can plant-based omega-3 replace fish oil?
No. Plant-based omega-3 provides ALA, which converts to EPA at below 5% efficiency and to DHA at below 0.5% efficiency in humans. For people relying on flaxseed, chia, or walnuts as their omega-3 source, actual EPA and DHA intake is negligible compared to what fish oil provides directly.
What is the ALA to EPA conversion rate in humans?
Peer-reviewed research consistently finds ALA-to-EPA conversion rates of 0.2% to 8%, with most studies below 5%. ALA-to-DHA conversion is typically below 0.5%. These rates are too low to achieve meaningful EPA and DHA status from ALA alone.
Why is ALA conversion so inefficient?
The conversion enzymes (delta-6 desaturase) are rate-limited and shared with omega-6 metabolism. High omega-6 intake — typical in Western diets — competitively inhibits ALA conversion. Much ALA is also used as energy rather than converted to EPA.
Who needs preformed EPA and DHA?
Anyone not consuming 2–3 servings of fatty fish per week — including vegans, vegetarians, people with fish allergies, older adults (declining conversion efficiency), and pregnant women (high DHA demand for foetal development).
* Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
Sources:
Brenna JT et al. — ALA supplementation and conversion to EPA/DHA, AJCN (2009)
Burdge GC — ALA metabolism in men, Br J Nutr (2002)
NeoLife Omega 3 Plus — Ultra-Pure Marine Omega-3 in Triglyceride Form